GURUFOCUS.COM » STOCK LIST » Technology » Software » Earth Life Sciences Inc (OTCPK:CLTS) » Definitions » EV-to-EBIT

Earth Life Sciences (Earth Life Sciences) EV-to-EBIT : -1.91 (As of Apr. 26, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Earth Life Sciences EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Earth Life Sciences's Enterprise Value is $0.67 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Therefore, Earth Life Sciences's EV-to-EBIT for today is -1.91.

The historical rank and industry rank for Earth Life Sciences's EV-to-EBIT or its related term are showing as below:

CLTS's EV-to-EBIT is not ranked *
in the Software industry.
Industry Median: 17.375
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -5.16%.


Earth Life Sciences EV-to-EBIT Historical Data

The historical data trend for Earth Life Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Earth Life Sciences EV-to-EBIT Chart

Earth Life Sciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -139.73 -7.67 -66.84 -3.36 -4.12

Earth Life Sciences Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.56 -6.79 -4.12 -30.73 -19.39

Competitive Comparison of Earth Life Sciences's EV-to-EBIT

For the Information Technology Services subindustry, Earth Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Earth Life Sciences's EV-to-EBIT Distribution in the Software Industry

For the Software industry and Technology sector, Earth Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Earth Life Sciences's EV-to-EBIT falls into.



Earth Life Sciences EV-to-EBIT Calculation

Earth Life Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.668/-0.349
=-1.91

Earth Life Sciences's current Enterprise Value is $0.67 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Earth Life Sciences  (OTCPK:CLTS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) =EBIT / Enterprise Value (Q: Sep. 2022 )
=-0.349/6.767298
=-5.16 %

Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Earth Life Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Earth Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Earth Life Sciences (Earth Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
828 Harbourside Drive, Suite 209, North Vancouver, BC, CAN, V7P 3R9
Earth Life Sciences Inc offers Artificial Intelligence (AI)-driven mileage-based loyalty system for public transportation. The Miltean's AI platform enables an increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns. The firm caters to public traffic management systems and team up relationships between private and public enterprise.
Executives
John Farinaccio director, officer: Vice President 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Jocelyn Moisan director, officer: Predident 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
George Tsolakos officer: VP Business Development 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Angelo M Marino director, officer: Secretary and Vice President 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Uwd Unitas World Development Inc. 10 percent owner 7000 COTE DE LIESSE, SUITE 8, MONTREAL A8 H4T 1E7
Greg A Thompson director 11123 TUPPER LAKE DRIVE, HOUSTON TX 77042
Darrell Parlee officer: Treasurer 2144 CROWBRIDGE DRIVE, FRISCO TX 75034
Andy Kim director 1408 STONE CUTTER DR., OAKVILLE A1 00000
Steve Bajic officer: Secretary 918-1030 WEST GEORGIA STREET, VANCOUVER A1 V6E 2Y3
Donald L Sytsma director, officer: CFO and Treasurer 2404 ECHO HARBOR DRIVE, PEARLAND TX 77584
Bassam Nastat director 5631 WINCH ST, BURNABY BC A1 V5B 2J4
Milton Cox director, officer: President 7227 WINCHESTER RD #258, MEMPHIS TN 38118
Michael P Twyman director, 10 percent owner, officer: President
Andrew B Stewart director, 10 percent owner, officer: Secretary 1208 1030 W GEORGIA ST, VANCOUVER BC A1 9999999999

Earth Life Sciences (Earth Life Sciences) Headlines

From GuruFocus

Earth Life Sciences Inc. Corporate Update

By Marketwired Marketwired 12-18-2018

Earth Life Sciences: Corporate up-date & New Projects

By PRNewswire PRNewswire 06-06-2018

Acquisition of Technology

By Marketwired Marketwired 01-06-2020

The Future of CBDs and Earth Life Sciences

By Marketwired Marketwired 01-22-2019

Earth Life Sciences Inc. Announces Recent Activities

By Marketwired Marketwired 12-16-2019

Earth Life Sciences New Domain Name for Viva Health Services

By ACCESSWIRE ACCESSWIRE 10-06-2021

Earth Life Sciences Updates Corporate Status

By Marketwired Marketwired 01-08-2019